ILUMYA® (tildrakizumab-asmn) approved in the U.S. for the Treatment of Adults with Active Psoriatic Arthritis

The Quick Take
IL-23 inhibitor approved exclusively for healthcare provider-administered treatment Expands use of ILUMYA beyond moderate-to-severe plaque psoriasis strengthening Sun Pharma's portfolio in psoriatic disease MUMBAI, India and PRINCETON, N.J., Oct. 30, 2026 /PRNewswire/ -- Sun...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire General Business.
Related
Business
HIZENERGY prezentuje pełną gamę rozwiązań w zakresie akumulatorowych systemów magazynowania energii dla sektora komercyjnego i przemysłowego, wspierających transformację energetyczną w Europie
FRANKFURT, Niemcy, 30 października 2026 r. /PRNewswire/ -- Dr Fei Wang, menedżer ds. rozwiązań w HIZENERGY, wygłosił wystąpienie przewodnie, podczas którego…
Business
Deloitte Wins Inaugural AI Leadership Honor and Ninth Consecutive 'Tax Technology Firm of the Year' Award at 2026 ITR Americas Tax Awards
ITR recognized Deloitte across nine categories spanning tax technology, transfer pricing, innovation, advisory, global mobility and compliance and reporting…
Local
San Diego Broker and Author Releases Edition 2 of She Gave Her Pearls -- With a New Epilogue Written After Betty Broderick's Death -- Ahead of the 37th Anniversary
The only Broderick account built from the property record: three years tracing 30 years of purchases, loans, and payoffs through public documents. SAN DIEGO,…
Business
University of Phoenix leader shares strategies for student-centered digital learning at WCET Annual Conference
Kelly Hermann presented sessions on governance, documentation and institutional strategies that support equitable learning experiences PHOENIX, Oct. 30, 2026…
